No Data
Express News | Haemonetics Q2 Adjusted Free Cash Flow USD 49 Million
Express News | Haemonetics Q2 EPS USD 0.66
Express News | Haemonetics Q2 Adjusted EPS USD 1.12 Vs. IBES Estimate USD 1.07
Express News | Haemonetics Q2 Revenue USD 346 Million Vs. IBES Estimate USD 342.6 Million
Here's Why You Should Add OMCL Stock to Your Portfolio Now
Needham Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $112